Literature DB >> 16076959

Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation.

Hitomi Matsuzaki1, Hiroaki Daitoku, Mitsutoki Hatta, Hisanori Aoyama, Kenji Yoshimochi, Akiyoshi Fukamizu.   

Abstract

The FOXO family of forkhead transcription factors plays a key role in a variety of biological processes, including metabolism, cell proliferation, and oxidative stress response. We previously reported that Foxo1, a member of the FOXO family, is regulated through reversible acetylation catalyzed by histone acetyltransferase cAMP-response element-binding protein (CREB)-binding protein (CBP) and NAD-dependent histone deacetylase silent information regulator 2, and that the acetylation at Lys-242, Lys-245, and Lys-262 of Foxo1 attenuates its transcriptional activity. However, the molecular mechanism by which acetylation modulates Foxo1 activity remains unknown. Here, we show that the positive charge of these lysines in Foxo1 contributes to its DNA-binding, and acetylation at these residues by CBP attenuates its ability to bind cognate DNA sequence. Remarkably, we also show that acetylation of Foxo1 increases the levels of its phosphorylation at Ser-253 through the phosphatidylinositol 3-kinase-protein kinase B signaling pathway, and this effect was overridden on the acetylation-deficient Foxo1 mutant. Furthermore, in in vitro kinase reactions, the association of wild-type Foxo1 and its target DNA sequence inhibits the protein kinase B-dependent phosphorylation of Foxo1, whereas mutated Foxo1 proteins, which mimic constitutively acetylated states, are efficiently phosphorylated even in the presence of the DNA. These results suggest that acetylation regulates the function of Foxo1 through altering the affinity with the target DNA and the sensitivity for phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076959      PMCID: PMC1183558          DOI: 10.1073/pnas.0502738102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Direct control of the Forkhead transcription factor AFX by protein kinase B.

Authors:  G J Kops; N D de Ruiter; A M De Vries-Smits; D R Powell; J L Bos; B M Burgering
Journal:  Nature       Date:  1999-04-15       Impact factor: 49.962

2.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

Review 3.  FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.

Authors:  Domenico Accili; Karen C Arden
Journal:  Cell       Date:  2004-05-14       Impact factor: 41.582

4.  Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.

Authors:  Masahiro Aoki; Hao Jiang; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

Review 5.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

6.  Hepatocyte nuclear factor 3/fork head or "winged helix" proteins: a family of transcription factors of diverse biologic function.

Authors:  E Lai; K L Clark; S K Burley; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

7.  Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation.

Authors:  Hitomi Matsuzaki; Hiroaki Daitoku; Mitsutoki Hatta; Keiji Tanaka; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

8.  Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.

Authors:  Hiroaki Daitoku; Mitsutoki Hatta; Hitomi Matsuzaki; Satoko Aratani; Takayuki Ohshima; Makoto Miyagishi; Toshihiro Nakajima; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

9.  FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1).

Authors:  Armando van der Horst; Leon G J Tertoolen; Lydia M M de Vries-Smits; Roy A Frye; René H Medema; Boudewijn M T Burgering
Journal:  J Biol Chem       Date:  2004-05-04       Impact factor: 5.157

10.  Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo.

Authors:  Jianyuan Luo; Muyang Li; Yi Tang; Monika Laszkowska; Robert G Roeder; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  188 in total

Review 1.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

2.  Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.

Authors:  Nima Alamdari; Ira J Smith; Zaira Aversa; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

3.  Increased acetylation in the DNA-binding domain of TR4 nuclear receptor by the coregulator ARA55 leads to suppression of TR4 transactivation.

Authors:  Shaozhen Xie; Jing Ni; Yi-Fen Lee; Su Liu; Gonghui Li; Chih-Rong Shyr; Chawnshang Chang
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

4.  Lysine methylation of FOXO3 regulates oxidative stress-induced neuronal cell death.

Authors:  Qi Xie; Yumin Hao; Li Tao; Shengyi Peng; Chitong Rao; Hong Chen; Han You; Meng-qiu Dong; Zengqiang Yuan
Journal:  EMBO Rep       Date:  2012-04       Impact factor: 8.807

5.  Putting the brakes on FOXO1 in fat.

Authors:  Jane J Kim; Wuqiang Fan; Jerrold M Olefsky
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598

6.  FOXO transcription factors in non-alcoholic fatty liver disease.

Authors:  X Charlie Dong
Journal:  Liver Res       Date:  2017-09

7.  Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction.

Authors:  Hye Jin Wang; Jae Yeo Park; Obin Kwon; Eun Yeong Choe; Chul Hoon Kim; Kyu Yeon Hur; Myung-Shik Lee; Mijin Yun; Bong Soo Cha; Young-Bum Kim; Hyangkyu Lee; Eun Seok Kang
Journal:  Autophagy       Date:  2015-11-02       Impact factor: 16.016

Review 8.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 9.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

10.  Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Authors:  Brittney Jung-Hynes; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.